1 year return (CAGR)
-62.16%
aTyr Pharma, Inc. Exchange (NASDAQ, USD)
ATYR
0.38
-0.01 (-1.31%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-38.61%
5 year return (CAGR)
-40.84%
10 year return (CAGR)
-37.77%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
37.68M
Price/Sales
198.29
Ent value
42.75M
Price/Book
0.78
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-14.76%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.40 |
| Daily high | 0.40 |
| Daily low | 0.38 |
| Daily Volume | 942K |
| All-time high | 390.32 |
| 1y analyst estimate | 2.86 |
| Beta | 0.52 |
| EPS (TTM) | -0.62 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ATYR | S&P500 | |
| Current price drop from All-time high | -99.90% | -3.06% |
| Highest price drop | -99.90% | -56.47% |
| Date of highest drop | 16 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -93.31% | -10.68% |
| Avg time to new high | 317 days | 12 days |
| Max time to new high | 2839 days | 1805 days |
News
